Trials / Unknown
UnknownNCT01855165
The Role of Clinical Pharmacist in Management of DDIs in CHF Patients
The Role of Clinical Pharmacist's Intervention in Management of Clinically Relevant Drug-drug Interactions in Patients With Chronic Heart Failure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- The University Clinic of Pulmonary and Allergic Diseases Golnik · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition. Data bases often detect DDIs that are of high clinical relevance. The investigators have performed this study in order to detect clinically significant DDIs and to diminish their occurrence by sending notification about DDIs to attending physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Advice on DDIs |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-05-16
- Last updated
- 2013-05-16
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT01855165. Inclusion in this directory is not an endorsement.